SCHEMBL348694

SCHEMBL348694

O=[C]Cc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306440 0.81 — —
SCHEMBL327550 0.77 — —
SCHEMBL837048 0.76 — —
SCHEMBL3228483 0.76 — —
SCHEMBL6545428 0.76 — —
SCHEMBL29051227 0.74 ALDH1A1 (0.41) —
SCHEMBL3284871 0.74 ALDH1A1 (0.58) —
SCHEMBL315507 0.74 — —
SCHEMBL29058846 0.73 — —
SCHEMBL10768701 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 496 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110343075-B 1,2, 4-triazole piperazine amide derivative containing 3,4, 5-trimethoxyphenyl and application thereof 贵阳学院 2021-01-29 — — CN claimed
CN-110343075-A A kind of 1,2,4- triazole piperazine amide analog derivative of the trimethoxyphenyl containing 3,4,5- and its application 贵阳学院 2019-10-18 — — CN claimed
US-10239908-B2 Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto SOMALOGIC, INC. (US) 2019-03-26 — — US claimed
US-20180201641-A1 Cytidine-5-Carboxamide Modified Nucleotide Compositions and Methods Related Thereto SOMALOGIC OPERATING CO. INC. 2018-07-19 — — US claimed
EP-3330277-A2 CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO Somalogic, Inc. (US) 2018-06-06 — — EP claimed
US-9938314-B2 Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto SOMALOGIC, INC. (US) 2018-04-10 — — US claimed
EP-3071588-A1 CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO Somalogic, Inc. (US) 2016-09-28 — — EP claimed
WO-2015077292-A1 CYTIDINE-5-CARBOXAMIDE MODIFIED NUCLEOTIDE COMPOSITIONS AND METHODS RELATED THERETO SOMALOGIC, INC. (US) 2015-05-28 — — WO claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 — — EP claimed
US-20120277164-A1 GADD45BETA TARGETING AGENTS IMPERIAL INNOVATIONS LIMITED (GB) 2012-11-01 — — US claimed
US-4277482-A AMINO ACID DERIVATIVE ANTIBIOTICS MERCK & CO., INC. (US) 1981-07-07 — — US claimed
EP-0000645-B1 ISOPENICILLINS, PROCESSES FOR THEIR PREPARATION, AND COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1981-01-28 — — EP claimed
US-4226866-A BACTERICIDES, ACYLATION MERCK & CO., INC. (US) 1980-10-07 — — US claimed
US-4215124-A ANTIBIOTICS MERCK & CO., INC. (US) 1980-07-29 — — US claimed
US-4159267-A Novel silyl ester azetidine-2-sulfenate intermediates and process for preparing desacetoxycephalosporins ELI LILLY AND COMPANY (US) 1979-06-26 — — US claimed
EP-0002210-A1 6- and 6,6- disubstituted-2-substituted-pen-2-em-3-carboxylic acids; processes for their preparation and pharmaceutical compositions containing such compounds MERCK & CO. INC. (US) 1979-06-13 — — EP claimed
US-4086423-A CEPHALOSPORINS, CYCLOADDITION OF GLYCINE DERIVATIVE TO THIAZINE COMPOUND MERCK & CO., INC. (US) 1978-04-25 — — US claimed
US-4032521-A ANTIBIOTICS MERCK & CO., INC. (US) 1977-06-28 — — US claimed
US-3965098-A Intermediates for preparing cephalosporins and methods of production AMERICAN HOME PRODUCTS CORPORATION (US) 1976-06-22 — — US claimed
US-3935198-A BY HEATING THE PENICILLIN SULFOXIDE YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) 1976-01-27 — — US claimed
Send feedback